Genpact Limited (NYSE:G) Shares Acquired by DGS Capital Management LLC

DGS Capital Management LLC boosted its position in Genpact Limited (NYSE:GFree Report) by 31.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,319 shares of the business services provider’s stock after purchasing an additional 3,682 shares during the quarter. DGS Capital Management LLC’s holdings in Genpact were worth $505,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. ARGA Investment Management LP grew its holdings in Genpact by 127.2% in the 1st quarter. ARGA Investment Management LP now owns 385,043 shares of the business services provider’s stock valued at $12,687,000 after buying an additional 215,606 shares during the period. Ballentine Partners LLC increased its position in Genpact by 29.3% during the first quarter. Ballentine Partners LLC now owns 11,783 shares of the business services provider’s stock worth $388,000 after purchasing an additional 2,667 shares during the last quarter. Birch Capital Management LLC raised its stake in Genpact by 21.6% during the first quarter. Birch Capital Management LLC now owns 36,952 shares of the business services provider’s stock worth $1,218,000 after purchasing an additional 6,563 shares during the period. Running Oak Capital LLC boosted its holdings in shares of Genpact by 19.6% in the 1st quarter. Running Oak Capital LLC now owns 241,438 shares of the business services provider’s stock valued at $7,955,000 after purchasing an additional 39,592 shares during the last quarter. Finally, Tealwood Asset Management Inc. raised its position in shares of Genpact by 8.0% in the 1st quarter. Tealwood Asset Management Inc. now owns 24,634 shares of the business services provider’s stock worth $812,000 after buying an additional 1,818 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Wall Street Analysts Forecast Growth

G has been the subject of several research analyst reports. StockNews.com lowered Genpact from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 5th. Wedbush reiterated a “neutral” rating and set a $35.00 price objective on shares of Genpact in a research note on Friday, May 10th. Citigroup lowered their price target on Genpact from $36.00 to $33.00 and set a “neutral” rating for the company in a report on Monday, April 22nd. Needham & Company LLC restated a “buy” rating and set a $40.00 price objective on shares of Genpact in a research note on Friday, May 10th. Finally, BMO Capital Markets lowered their target price on Genpact from $39.00 to $38.00 and set a “market perform” rating for the company in a research note on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $38.00.

Check Out Our Latest Report on G

Genpact Stock Performance

Genpact stock opened at $32.00 on Friday. Genpact Limited has a 52 week low of $29.41 and a 52 week high of $39.58. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.36. The stock has a market cap of $5.76 billion, a P/E ratio of 9.14, a price-to-earnings-growth ratio of 1.49 and a beta of 1.12. The stock has a 50 day moving average of $32.45 and a 200-day moving average of $33.63.

Genpact (NYSE:GGet Free Report) last issued its earnings results on Thursday, May 9th. The business services provider reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.06. The business had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.11 billion. Genpact had a net margin of 14.21% and a return on equity of 22.71%. On average, analysts expect that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Stockholders of record on Monday, June 10th were issued a $0.153 dividend. The ex-dividend date was Monday, June 10th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.91%. Genpact’s dividend payout ratio (DPR) is 17.43%.

Insider Buying and Selling at Genpact

In related news, Director N. V. Tyagarajan sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $33.17, for a total transaction of $33,170.00. Following the completion of the transaction, the director now owns 7,300 shares in the company, valued at approximately $242,141. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.80% of the stock is owned by insiders.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.